Screening: The Significance of Pheochromocytoma
- PMID: 33759746
- PMCID: PMC8182781
- DOI: 10.3238/arztebl.m2021.0042
Screening: The Significance of Pheochromocytoma
Comment in
-
In Reply.Dtsch Arztebl Int. 2021 Jan 29;118(4):56. doi: 10.3238/arztebl.m2021.0043. Dtsch Arztebl Int. 2021. PMID: 33759747 Free PMC article. No abstract available.
Comment on
-
The Neurofibromatoses.Dtsch Arztebl Int. 2020 May 15;117(20):354-360. doi: 10.3238/arztebl.2020.0354. Dtsch Arztebl Int. 2020. PMID: 32657748 Free PMC article. Review.
References
-
- Bausch B, Borozdin W, Mautner VF, et al. Germline NF1 mutational spectra and loss of heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab. 2007;92:2784–2792. - PubMed
-
- Koch CA, Gimm G, Vortmeyer AO, et al. Does the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy ? Ann NY Acad Sci. 2006;1073:517–526. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
